MedPath
NMPA Approval

Ibrutinib Capsules

国药准字H20223719

October 11, 2022

Drug Information

伊布替尼胶囊

胶囊剂

140mg

化学药品

October 11, 2022

Company Information

Applicant Company

海南省海口市秀英区药谷一横路20号

Manufacturing Company

江苏省南京江北新区华康路99号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

伊布替尼胶囊 - NMPA 批准文号 | MedPath